These results, although limited, le

These results, although limited, lend support to the theory that only
those drug licenses that issued predictably in significant markets are likely
to harm innovation. Of the six companies subjected to compulsory licensing,
Merieux was the only one that exhibited a decline in patenting.
Merieux’s licensing event was the only one that was both anticipated and
affected a market that was significant to the company. Although the data
used in this study cannot prove that the licensing event caused Merieux’s
decline in patenting, it does indicate how pharmaceutical companies might
react to these types of compulsory licenses.

Hasil (Bahasa Indonesia) 1:

Hasil ini, meski terbatas, memberikan dukungan kepada teori yang hanyamereka obat lisensi yang dikeluarkan diduga di pasar signifikan kemungkinannyamerugikan inovasi. Dari enam perusahaan mengalami lisensi wajib,Merieux adalah satu-satunya yang dipamerkan penurunan paten.Acara perizinan Merieux's adalah satu-satunya yang keduanya diantisipasi danmempengaruhi pasar yang signifikan kepada perusahaan. Meskipun datadigunakan dalam studi tidak dapat membuktikan bahwa acara perizinan disebabkan Merieux'spenurunan dalam paten, itu menunjukkan bagaimana mungkin perusahaan farmasibereaksi terhadap jenis lisensi wajib.